(Total Views: 605)
Posted On: 11/17/2020 10:58:01 AM
Post# of 154016
Burn the ship! I totally agree. This is a sure sign to me we are unblinding at the 75% interim look. The results Nader expects as most of us do. Must be able to achieve revenue. A sure sign of confidence is what this move is.
We are not limited to just the FDA for an approval. We cherish the FDA approval because it is a standard once used to ease other countries doubts. With Covid and 3 quick FDA EUA’s on drugs that don’t do anything or not much if anything. The reputation we seek from an FDA approval isn’t what it once was. When we have realized that and moved forward with potential to show our results around the world with or without the FDA stamp of approval. We will still have revenue. My guess still is that the U.K. will be the first to commercial sales for Vyrologix for Covid and soon thereafter our first HIV approval.
We are not limited to just the FDA for an approval. We cherish the FDA approval because it is a standard once used to ease other countries doubts. With Covid and 3 quick FDA EUA’s on drugs that don’t do anything or not much if anything. The reputation we seek from an FDA approval isn’t what it once was. When we have realized that and moved forward with potential to show our results around the world with or without the FDA stamp of approval. We will still have revenue. My guess still is that the U.K. will be the first to commercial sales for Vyrologix for Covid and soon thereafter our first HIV approval.
(3)
(1)
